SL Science Holding Limited Ordinary Shares (SLBT) is a publicly traded the market company. As of October 26, 2026, SLBT trades at $1.24 with a market cap of $644.87M and a P/E ratio of 0.00. SLBT moved -5.22% today. Year to date, SLBT is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $1.02 to $14.50. Rallies surfaces SLBT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
SL Science revenue rose 23%, but first-half net loss widened 35% to $2.16 million: For the six months ended June 30, 2026, revenue rose 23% to $1.39 million and gross margin improved to 40.2%, while net loss widened 35% to $2.16 million. Cash and cash equivalents reached $8.31 million, and the company secured $7.8 million in PIPE financing alongside its Nasdaq listing.
| Metric | Value |
|---|---|
| Price | $1.24 |
| Market Cap | $644.87M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.31% |
| 52-Week High | $14.50 |
| 52-Week Low | $1.02 |
| Volume | 51.93K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
SLBT analyst coverage data. Average price target: $0.00.